|
| Exchange Disseminated Time | Natco Pharma Ltd has informed BSE that a meeting of the Board of Directors of the Company will be held on February 11, 2016, inter alia, to consider the following:
1. The unaudited financial Results for the quarter and nine months ended December 31, 2015 and related matters (Q3).
2. To consider Interim Dividend, if any, for the financial year 2015-16 and related matters etc.
Further, the Trading Window for dealing in the securities of the Company will be closed for Promoters, Directors, Connected Persons, Insiders, Employees and their immediate relatives from February 03, 2016 to February 13, 2016 (both days inclusive). It will be opened from February 15, 2016. |
|
|